Latest

The day's market news, with the argument attached

New notes every trading day on earnings, policy and market structure. Each one opens with the conclusion, then the evidence, then the companies it hits.

What Big Funds Own22 fundsWhat Berkshire, Bridgewater and other big funds reported holding last quarter.What Analysts Expect16 stocksRatings and price targets from the big institutions, each with its public source.

2026-08-10

Anthropic turns $30B run-rate into a cyber “industry operating system” with Project Glasswing insight cover

Private Company

Aug 10, 2026

8 min read

Anthropic turns $30B run-rate into a cyber “industry operating system” with Project Glasswing

Anthropic disclosed a revenue run-rate above $30B and simultaneously launched Project Glasswing, a large, partner-wide defensive cybersecurity effort centered on access to Claude Mythos Preview. The strategic signal isn’t just that Anthropic has “AI security capability”—it’s that Anthropic is trying to convert enterprise trust and regulated buyer demand into a repeatable, credit-funded product line that rides on cloud + security vendor distribution.

Broadcom FY2024 revenue: $51.57BPalo Alto Networks FY2024 revenue: $8.03B

Claude Code flips auto/agent mode to default—so integrators, not end-users, inherit the operational liability

Starting August 14, Anthropic will run Claude Code in auto mode by default for Pro, Max, and Team plans, routing more permission decisions to model-based classifiers instead of step-by-step human approvals. The key shift is liability distribution: when coding agents start acting with less friction, the blast-radius now moves toward enterprise integrators and IDE/toolchain owners, even as Anthropic reports auto mode blocking 89% of dangerous commands in a 1,053-tester study.

Human review catch rate: 13.6%Auto-mode block rate: 89%

Appaloosa’s Q2 pivot bets the AI capex chain is still mispriced—and its “walk-away-from-banks” move tightens the signal

Appaloosa Management (David Tepper) reportedly rotated its Q2 2026 13F exposure toward AI infrastructure—highlighting a sharp add to Micron and a larger position in Amazon, with Taiwan Semi also pushed into core territory—while exiting bank holdings entirely. The investable takeaway isn’t “AI good, banks bad”; it’s that memory + foundry + hyperscaler demand signals can re-rate margins and capex intensity even when financials look safer on paper.

Micron FY2025 revenue: $37.38BMicron FY2025 net income: $8.54B

Archer just bought Boeing’s autonomous-air-taxi stack for ~19.75% equity—turning eVTOL consolidation into a flight-certification supply story

Archer Aviation’s planned all-equity purchase of Boeing’s [Wisk Aero], [SkyGrid], and [Insitu] subsidiaries gives Boeing an ~19.75% stake plus $200M of option-like warrants—effectively bundling a certification-and-operations pathway into Archer’s capital plan. The deal reframes “autonomous air taxi” from a software thesis into an integrated, Boeing-adjacent supplier of flight, sensing, and airspace integration assets.

Closing date window: End of 2026Boeing stake (Class A): 19.75%

Atlassian's Cloud +31% delivers the AI “attach” proof the enterprise SaaS market has been waiting for

In Q4 FY2026, Atlassian posted $1.766B revenue (+28% YoY) with Cloud revenue at $1.213B (+31% YoY) and $4.8B in RPO (+44%). The key investor takeaway isn’t another AI feature demo—it’s that Cloud acceleration is happening alongside AI-led product momentum, which changes how investors underwrite the monetization timeline from “promises” to “line-item traction.”

Total revenue (Q4 FY26): $1.766BCloud revenue (Q4 FY26): $1.213B

Australia turns rare-earth mining into a security-controlled asset class by ordering Chinese-linked owners to sell

Australia’s foreign investment enforcement is moving beyond export controls and into equity control for Western rare-earth projects. By freezing shareholder rights and ordering Chinese-linked investors to divest Northern Minerals stakes, the policy effectively re-prices the governance premium investors will demand for future funding and licensing in critical minerals.

MP Materials FY2024 revenue: $203.9MMP Materials FY2024 net income: -$97.1M

Bristol Myers’ $2.3B Houston campus turns pharma reshoring into build-out of finished-goods capacity

Bristol Myers is committing about $2.3B to a new multi-modal manufacturing campus in Houston, with ~600,000 sq ft sized for small molecules, biologics and antibody-drug conjugates. Framed alongside Reuters’ “tariff threat” push, the investor takeaway is that the reshoring wave is shifting from announcements to hard, finished-product capacity—raising near-term demand for engineering, CDMO services, and lab/bioprocess tooling while compressing execution risk into 2027–2030 timelines.

Investment size: ~$2.3BCampus size: ~600,000 sq ft

China’s “domestic capital” AI doctrine makes US AI capex less dollar-dominant—look for memory suppliers to win while GPU capex gets quietly rerouted

Beijing’s $28T-style push to fund AI via onshore markets (with CXMT as the prototype) changes how capital is allocated: fewer “must-spend” dollar capex cycles for the US hyperscaler stack, more onshore production funding for bottleneck components. In parallel, DeepSeek’s reported fundraising pause highlights the other side of the doctrine—AI funding is now market-conditional, not subsidy-automatic.

Micron revenue (TTM): $90.27BMicron net cash from ops (TTM): $51.43B

CyrusOne’s 2027 IPO Signal Re-Ratings for “Independent” Data Centers—Because Lenders Are Making Financing a Valuation Variable

CyrusOne is preparing a potential 2027 IPO and has been in discussions with banks about roles, per Reuters. If that listing proceeds, it could force public-market re-pricing across the independent colocation/data-center stack just as tighter lender scrutiny makes leverage and refinancing risk a first-order valuation input.

Equinix: trailing P/E: 67.09Equinix: EV/EBITDA: 27.81

Community opposition is becoming a credit risk—so lenders are shifting data-center financing toward “permit-friendly” states

A Reuters report says lenders are now explicitly folding community opposition into project readiness and drawdown risk. That turns NIMBY/permitting friction into an underwriting variable, which can reorder which markets and operators get built first—and who pays the higher cost of delay.

Blocked/delayed projects (Q1 2026): 75Value at stake: $130B

The Real Bottleneck Isn’t Rack Cooling—It’s the IP Stack Behind the Thermal Interface That Makes AI Chips Work

Discovered Materials’ AI-driven “whack-a-mole” approach to finding cooler thermal materials highlights how fast the industry has to iterate to avoid thermal throttling. But the investable constraint is upstream: the process, deposition, and materials IP that can manufacture new thermal interface layers reliably at scale—where Applied Materials sits and where materials suppliers like Shin-Etsu Chemical and Tokyo Ohka Kogyo are built to monetize.

Applied Materials revenue (TTM): $29.0BApplied Materials gross margin (TTM): 49%

Fisher’s AI-Infrastructure Crowding Trade Is Real—But It’s the “Grid-to-Aircraft-to-Network” Link That Should Matter for Investors

Fisher Asset Management’s latest 13F (quarter ended June 30, 2026) shows aggressive positioning across AI’s “real economy” buildout—power and electrification via GE Vernova, aerospace platforms via GE Aerospace, and enterprise/data-center connectivity via Cisco Systems, alongside the usual AI compute core. The investable takeaway is not that AI exists—it’s that Fisher is paying up for the bottlenecks and replacement cycles that sit between AI demand and the supply chain that fulfills it.

GE Vernova Q2 revenue: $11.1BGE Vernova Q2 net income: $668M

Hims & Hers turns subscriber growth into guidance proof—telehealth becomes a volume platform

In its latest earnings update, Hims & Hers reported subscribers rising to nearly 2.6M (+9% YoY) and raised full-year 2026 revenue guidance to $2.8B–$3.0B. The key investor takeaway is that the company’s top-line beat is now subscriber-driven—supporting a shift from “one-product GLP-1 cycle” risk to a broader telehealth platform with measurable, repeatable volume.

Subscribers (Q1 2026, end of period): 2.584MFY2026 revenue guidance: $2.8B–$3.0B

Instacart's ads are outgrowing transactions because grocery data still converts—so the retail e-commerce ad channel is “real demand,” not a funding-cycle artifact

Instacart grew Q2 2026 Advertising & other revenue +16% YoY while transaction revenue rose +13% YoY, with GTV +14% YoY—an uncommon retail pattern where ad-load expands without visibly harming order growth. The proof point is cash too: Q2 free cash flow surged to $480M (+156% YoY), making it harder to dismiss the ad acceleration as purely “spend-driven.”

Q2 2026 GTV: $10.351BQ2 2026 Revenue: $1.043B

Intel selling $15B of new stock turns the turnaround rally into dilution math

Intel’s proposed $15B common-stock offering (plus a $2.25B underwriter option) gives management capital for capex/working capital—but it also means investors are funding the foundry ramp with fresh share issuance at a high-price tape. The market implication is straightforward: even if foundry timelines improve, per-share economics get worse until operating leverage arrives.

TTM revenue: $57.0BTTM operating cash flow: $14.9B

Alphabet's talent exodus risk: investors should watch whether CEO-level AI capex and recruiting intensity rise after Jeff Dean-style departures

When Jeff Dean and other senior Google AI researchers left to launch [Discovery Loop], the headline wasn’t just a startup story—it was a signal that top-model talent can be a bottleneck that forces hyperscalers to spend more to stay competitive. Alphabet already shows heavy reinvestment capacity, but the market should now price in whether leadership churn increases hiring and compute-cost pressure at the company level.

FY2025 revenue: $402.96BFY2025 R&D expense: $61.09B

UK calls Eli Lilly’s orforglipron “first in Europe” (10 Aug 2026)—and that sequencing risk compresses the EU/US GLP‑1 oral TAM while it’s still awaiting FDA/EMA timing

The UK’s MHRA authorized Eli Lilly’s oral GLP‑1, orforglipron (Foundayo), on 10 Aug 2026 as “the first country in Europe” for weight management and type 2 diabetes—before broader EU and US timing is locked. For investors, the key is not just access; it’s how an early UK regulatory imprimatur can reshape prescribing momentum, contracting expectations, and competitive sequencing while FDA review is still pending in the US.

FY 2025 revenue: $65.18BFY 2025 net income: $20.64B

Meta's Glimmer reframes AI capex as “agent infrastructure,” not a bigger chatbot

Meta is tying ~130B–145B capex guidance in 2026 to “AI efforts,” while launching Muse Glimmer as an open-weight, ~30B-parameter model optimized for always-on local agent workflows. The strategic implication is that Meta’s spend is increasingly rationalized by an always-running, user-specific agent loop—changing how compute, data, and distribution translate into revenue versus pure chatbot demos.

TTM revenue: $228.2BTTM R&D expense: $71.6B

Read article

Microsoft's September Maia 300 reveal tests whether custom inference silicon can undercut NVIDIA without breaking the supply chain insight cover

Industry News

Aug 10, 2026

MSFT · NVDA•8 min read

Microsoft's September Maia 300 reveal tests whether custom inference silicon can undercut NVIDIA without breaking the supply chain

Microsoft is signaling a next-generation custom AI accelerator (“Maia 300”) for a September public unveiling and 2027 deliveries. Its earlier Maia 200 already claims 30% better inference performance-per-dollar, so the real question isn’t specs—it’s whether Microsoft can scale volume enough to shift the inference cost curve and take share from NVIDIA’s full-stack economics.

Maia 200: performance-per-dollar claim: 30% betterMaia 200: scale-up cluster support: 6,144 accelerators

Rocket Lab's margin signal is a satellite-mix test: Q2 gross margin rose to 36.1% even as space-systems revenue shifted

In Rocket Lab's latest quarterly filing, Space Systems delivered most revenue ( $189.5M of $234.1M total) while Launch Services shrank, yet consolidated gross margin still rose to 36.1% from 32.1% a year earlier. The investment question isn’t whether satellite sales are growing—it’s whether Rocket Lab can keep space-service unit economics from resetting margins downward when lower-profit satellite-heavy revenue mix shows up in quarterly results.

Quarter gross margin: 36.1%Prior-year quarter gross margin: 32.1%

Read article

What to expect

Evidence-first notes with a visible point of view.

This section collects sharp takes on earnings, shareholder meetings, and market structure. Each new piece should make the thesis, the facts, and the implications obvious within the first few screens.

Expect direct analysis, not generic commentary.

Expect the data to be explicit and the argument to be easy to follow.

About UsPrivacy PolicyTerms of ServiceDisclaimerStock DirectoryETFsIndices13F HoldingsAnalyst TargetsFree ToolsTechnology MapJoin our Slack

Plutux is not an investment adviser. Market data and AI-generated analysis are for information and education only, not investment advice. Disclaimer